Please login to the form below

Not currently logged in
Email:
Password:

Donanemab

This page shows the latest Donanemab news and features for those working in and with pharma, biotech and healthcare.

Lilly and Banner Alzheimer’s Institute collaborate on donanemab prevention trial

Lilly and Banner Alzheimer’s Institute collaborate on donanemab prevention trial

Trial will evaluate donanemab in participants at risk for cognitive and functional decline related to Alzheimer’s. ... Donanemab is also being studied in the ongoing phase 3 TRAILBLAZER-ALZ 2 study in early symptomatic Alzheimer’s disease patients.

Latest news

More from news
Approximately 4 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Alzheimer’s: the search for a cure Alzheimer’s: the search for a cure

    Recently published study results for aducanumab and donanemab, both antibodies against amyloid, showed effects that indicated some improvement in cognition and daily function in patients with early Alzheimer’s. ... In the aforementioned aducanumab and

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Committing time to making meaningful connections - top 5 tips
Read the second blog of the series looking at key barriers to effective patient engagement in pharma...
News:
Senior Analytics Specialist joins Research Partnership...
Digital technologies: Pharma’s answer to achieving net zero emissions?
...